Your Shopping Cart
No Items
Article commentary by: Garth Hogan, Global Healthcare Services
The recently announced $69B CVS-Aetna deal is another great example of two companies wanting to create community healthcare hubs around the country for patients. This deal would provide a sort of one-stop shop similar to urgent care centers, but with a lot more services.
Right now, CVS has a little over 1,100 walk-in clinics within CVS facilities. Their footprint will likely start to increase.
The need for this change is driven by the demand for accessibility and convenience to patients who need care in all service areas, not just urban settings with ease of transportation. With a broader access point, providers will be able to discover, prevent and treat potential chronic illnesses. CVS locations are already community based and frequented by patients for more than just prescriptions and healthcare issues.
There’s a difference between the possible Aetna and CVS merger and existing retail care, in that this merger could favorably impact patient cost reduction with the “built-in” insurance component. Existing retail clinics provide convenience but are still set up under the current fee for service structure (private insurance/Medicare and Medicaid). There will be continued demand for retail medicine regardless.
Ideally, this could positively impact the existing in-patient facilities scattered throughout the US by creating significant cost savings in catching symptoms early enough to treat prior to requiring in-patient treatment.
Article written by: Shelby Livingston, Modern Healthcare, December 4, 2017
Through their $69 billion deal, CVS Health and Aetna are swinging an ax at the traditional ways in which patients access healthcare in hopes of building a new kind of model that's lower cost and more convenient for the consumer…
Posted on 12/14/2017 at 06:57 AM
All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.
